U.S. Markets open in 2 hrs 19 mins

Utah Medical Products Inc (UTMD) Files 10-K for the Fiscal Year Ended on December 31, 2017

- By insider

Utah Medical Products Inc ( UTMD ) files its latest 10-K with SEC for the fiscal year ended on December 31, 2017. Utah Medical Products Inc is in the business of producing medical devices that are predominantly proprietary, disposable and for hospital use. Utah Medical Products Inc has a market cap of $332.430 million; its shares were traded at around $89.35 with a P/E ratio of 22.85 and P/S ratio of 8.34. The dividend yield of Utah Medical Products Inc stocks is 1.18%. Utah Medical Products Inc had annual average EBITDA growth of 6.80% over the past ten years.


For the last quarter Utah Medical Products Inc reported a revenue of $10.2 million, compared with the revenue of $8.85 million during the same period a year ago. For the latest fiscal year the company reported a revenue of $41.4 million, an increase of 5.4% from last year. For the last five years Utah Medical Products Inc had an average revenue decline of 0.4% a year.

The reported diluted earnings per share was $3.897 for the year, an increase of 21% from previous year. Over the last five years Utah Medical Products Inc had an EPS growth rate of 5.9% a year. The Utah Medical Products Inc enjoyed an operating margin of 45.9%, compared with the operating margin of 41.19% a year before. The 10-year historical median operating margin of Utah Medical Products Inc is 37.01%. The profitability rank of the company is 7 (out of 10).

At the end of the fiscal year, Utah Medical Products Inc has the cash and cash equivalents of $40.0 million, compared with $26.3 million in the previous year. The company had no long term debt. Utah Medical Products Inc has a financial strength rank of 10 (out of 10).

At the current stock price of $89.35, Utah Medical Products Inc is traded at 94.6% premium to its historical median P/S valuation band of $45.92 . The P/S ratio of the stock is 8.34, while the historical median P/S ratio is 4.28. The stock gained 45.10% during the past 12 months.

CEO Recent Trades:

  • Chairman, CEO, Secretary Kevin L Cornwell sold 1,095 shares of UTMD stock on 02/22/2018 at the average price of $91.01. The price of the stock has decreased by 1.82% since.
  • Chairman, CEO, Secretary Kevin L Cornwell sold 150 shares of UTMD stock on 02/15/2018 at the average price of $91.13. The price of the stock has decreased by 1.95% since.

Directors and Officers Recent Trades:

  • Director Barbara A Payne sold 1,000 shares of UTMD stock on 02/16/2018 at the average price of $90.7. The price of the stock has decreased by 1.49% since.
  • Director Ernst G Hoyer sold 5,212 shares of UTMD stock on 02/15/2018 at the average price of $89.11. The price of the stock has increased by 0.27% since.
  • Director Ernst G Hoyer sold 1,529 shares of UTMD stock on 02/09/2018 at the average price of $88.08. The price of the stock has increased by 1.44% since.

For the complete 20-year historical financial data of UTMD, click here.

This article first appeared on GuruFocus.